Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE-/- mice.

Ganguly R, Sahu S, Ohanyan V, Haney R, Chavez RJ, Shah S, Yalamanchili S, Raman P.

Sci Rep. 2017 Mar 27;7:45279. doi: 10.1038/srep45279.

2.

Inverse Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control Study.

Chen S, Jin X, Shan Z, Li S, Yin J, Sun T, Luo C, Yang W, Yao P, Yu K, Zhang Y, Cheng Q, Cheng J, Bao W, Liu L.

Nutrients. 2017 Mar 17;9(3). pii: E294. doi: 10.3390/nu9030294.

3.

Effects of an amylopectin and chromium complex on the anabolic response to a suboptimal dose of whey protein.

Ziegenfuss TN, Lopez HL, Kedia A, Habowski SM, Sandrock JE, Raub B, Kerksick CM, Ferrando AA.

J Int Soc Sports Nutr. 2017 Feb 8;14:6. doi: 10.1186/s12970-017-0163-1. eCollection 2017.

4.
5.

Long-term Coexposure to Hexavalent Chromium and B[a]P Causes Tissue-Specific Differential Biological Effects in Liver and Gastrointestinal Tract of Mice.

Sánchez-Martín FJ, Fan Y, Carreira V, Ovesen JL, Vonhandorf A, Xia Y, Puga A.

Toxicol Sci. 2015 Jul;146(1):52-64. doi: 10.1093/toxsci/kfv070. Epub 2015 Mar 29.

6.

Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats.

Ulas M, Orhan C, Tuzcu M, Ozercan IH, Sahin N, Gencoglu H, Komorowski JR, Sahin K.

BMC Complement Altern Med. 2015 Feb 5;15:16. doi: 10.1186/s12906-015-0537-3.

7.

Chromium Therapy for Insulin Resistance Associated with HIV-Disease.

Stein SA, Mc Nurlan M, Phillips BT, Messina C, Mynarcik D, Gelato M.

J AIDS Clin Res. 2013 Sep 7;4(9). pii: 239.

8.

Chromium enhances insulin responsiveness via AMPK.

Hoffman NJ, Penque BA, Habegger KM, Sealls W, Tackett L, Elmendorf JS.

J Nutr Biochem. 2014 May;25(5):565-72. doi: 10.1016/j.jnutbio.2014.01.007. Epub 2014 Feb 20.

9.

Long-term exposure to low-concentrations of Cr(VI) induce DNA damage and disrupt the transcriptional response to benzo[a]pyrene.

Ovesen JL, Fan Y, Chen J, Medvedovic M, Xia Y, Puga A.

Toxicology. 2014 Feb 28;316:14-24. doi: 10.1016/j.tox.2013.12.001. Epub 2013 Dec 26.

10.

Long-term exposure to [Cr(3)O(O (2)CCH (2)CH (3)) (6)(H (2)O) (3)] (+) in Wistar rats fed normal or high-fat diets does not alter glucose metabolism.

Herring BJ, Logsdon AL, Lockard JE, Miller BM, Kim H, Calderon EA, Vincent JB, Bailey MM.

Biol Trace Elem Res. 2013 Mar;151(3):406-14. doi: 10.1007/s12011-012-9580-9. Epub 2012 Dec 29.

11.

Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity.

Masharani U, Gjerde C, McCoy S, Maddux BA, Hessler D, Goldfine ID, Youngren JF.

BMC Endocr Disord. 2012 Nov 30;12:31. doi: 10.1186/1472-6823-12-31.

12.

Severe insulin resistance treatment with intravenous chromium in septic shock patient.

Surani SR, Ratnani I, Guntupalli B, Bopparaju S.

World J Diabetes. 2012 Sep 15;3(9):170-3. doi: 10.4239/wjd.v3.i9.170.

13.

Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-α, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study.

Jain SK, Kahlon G, Morehead L, Dhawan R, Lieblong B, Stapleton T, Caldito G, Hoeldtke R, Levine SN, Bass PF 3rd.

Mol Nutr Food Res. 2012 Aug;56(8):1333-41. doi: 10.1002/mnfr.201100719. Epub 2012 Jun 6.

14.

Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-κB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats.

Selcuk MY, Aygen B, Dogukan A, Tuzcu Z, Akdemir F, Komorowski JR, Atalay M, Sahin K.

Nutr Metab (Lond). 2012 Apr 8;9:30. doi: 10.1186/1743-7075-9-30.

15.

Molecular mechanisms of chromium in alleviating insulin resistance.

Hua Y, Clark S, Ren J, Sreejayan N.

J Nutr Biochem. 2012 Apr;23(4):313-9. doi: 10.1016/j.jnutbio.2011.11.001. Review.

16.

Impact of chromium histidinate on high fat diet induced obesity in rats.

Tuzcu M, Sahin N, Orhan C, Agca CA, Akdemir F, Tuzcu Z, Komorowski J, Sahin K.

Nutr Metab (Lond). 2011 May 3;8:28. doi: 10.1186/1743-7075-8-28.

17.

Hypoglycaemic action of stevioside and а barley and brewer's yeast based preparation in the experimental model on mice.

Cekic V, Vasovic V, Jakovljevic V, Mikov M, Sabo A.

Bosn J Basic Med Sci. 2011 Feb;11(1):11-6.

18.

Trace elements in glucometabolic disorders: an update.

Wiernsperger N, Rapin J.

Diabetol Metab Syndr. 2010 Dec 19;2:70. doi: 10.1186/1758-5996-2-70.

19.

Author reply: Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.

Cefalu WT.

Metabolism. 2010 Nov;59(11):e18-9. doi: 10.1016/j.metabol.2010.07.017. No abstract available.

20.

Chromium supplementation improves glucose tolerance in diabetic Goto-Kakizaki rats.

Abdourahman A, Edwards JG.

IUBMB Life. 2008 Aug;60(8):541-8. doi: 10.1002/iub.84.

Supplemental Content

Support Center